title: Memantine: "hypothesis testing" not "disease modifying" in Alzheimer's disease.
authors.affiliation: Department of Neuroscience, University of Genova, Genova, Italy.
authors.forename: Massimo
authors.initials: M
authors.lastname: Tabaton
authors.forename: George
authors.initials: G
authors.lastname: Perry
authors.forename: Xiongwei
authors.initials: X
authors.lastname: Zhu
authors.forename: Hyoung-gon
authors.initials: HG
authors.lastname: Lee
authors.forename: Gemma
authors.initials: G
authors.lastname: Casadesus
authors.forename: Mark A
authors.initials: MA
authors.lastname: Smith
mesh_terms: D000544:Alzheimer Disease / Q000188:drug therapy / Q000209:etiology* / Q000378:metabolism / Q000473:pathology; D000682:Amyloid / Q000187:drug effects / Q000378:metabolism; D000818:Animals; D000978:Antiparkinson Agents / Q000494:pharmacology / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D003210:Concept Formation / Q000502:physiology; D004195:Disease Models, Animal; D004353:Drug Evaluation, Preclinical; D006801:Humans; D008559:Memantine / Q000494:pharmacology* / Q000627:therapeutic use; D051379:Mice; D008822:Mice, Transgenic; D013045:Species Specificity
chemical_list: D000682:Amyloid; D000978:Antiparkinson Agents; D008559:Memantine